Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Kimberly Batten
Introduction
Kimberly Batten is a prominent inventor based in Dallas, TX (US). She has made significant strides in the field of pharmaceuticals, particularly in the treatment of drug-resistant proliferative diseases. Her work focuses on innovative methods that leverage telomerase-mediated telomere altering compounds.
Latest Patents
Kimberly Batten holds 1 patent for her invention titled "Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds." This invention is directed toward pharmaceutical compositions and methods that utilize 6-mercaptopurine ribosides and their analogues for treating cancer and other hyperproliferative diseases. The compounds she developed can be converted into telomere substrates in vivo and recognized by telomerase for incorporation into the telomeres of telomerase-active cells. This process leads to the induction of cell death in those cells.
Career Highlights
Batten is affiliated with the University of Texas System, where she continues to contribute to groundbreaking research in her field. Her innovative approach to drug resistance in cancer treatment has positioned her as a key figure in pharmaceutical research.
Collaborations
Some of her notable coworkers include Jerry W. Shay and Ilgen Mender, who have collaborated with her on various research projects. Their combined expertise enhances the impact of their work in the scientific community.
Conclusion
Kimberly Batten's contributions to the field of pharmaceuticals demonstrate her commitment to advancing treatment options for challenging diseases. Her innovative patent and collaborations highlight her role as a leading inventor in the industry.